“What you have said is a terrible, terrible distortion of all the facts.” — CDC Advisory Committee on Immunization Practices (ACIP) member Cody Meissner, MD, of Dartmouth College in Hanover, New Hampshire, responding to a vaccine injury lawyer’s presentation on vaccine safety.
“If the political appointees running our health agencies and communities are going to ignore data and evidence, we must absolutely ignore them going forward.” — Michael Osterholm, PhD, MPH, of the University of Minnesota in Minneapolis, on ACIP’s vote to no longer recommend universal hepatitis B vaccination at birth.
“It is real. It is not all in people’s heads.” — Joel Stoddard, MD, of University of Colorado Anschutz in Aurora, on post-concert amnesia among Taylor Swift concert-goers.
“It was a knockout … We couldn’t find a weak point.” — Wojciech Jurczak, MD, PhD, of the Maria Skłodowska-Curie National Research Institute of Oncology in Kraków, Poland, on the reported efficacy of pirtobrutinib (Jaypirca) for newly diagnosed chronic lymphocytic leukemia/small lymphocytic lymphoma.
“Now that you see it allowing half-matched siblings and now in these genetically mismatched, unrelated donors, it’s really cool.” — Wendy Stock, MD, of the University of Chicago, commenting on post-transplant cyclophosphamide expanding the donor pool for stem cell transplants.
“In the beginning of the 2000s, most families could rely on being close to a hospital with substantial pediatric services … Now that has flipped.” — Kenneth Michelson, MD, MPH, of the Ann & Robert Lurie Children’s Hospital in Chicago, discussing the decline of hospitals with pediatric services.
“Despite the disappointment, it’s too early to write off GLP-1 therapies completely.” — Paul Edison, MD, PhD, of Imperial College London, discussing two phase III trials of semaglutide (Rybelsus) that failed to slow Alzheimer’s disease progression.
Please enable JavaScript to view the